Replies to post #1464 on Arrayit Corporation (ARYC)

[MikeCr]

I agree that Arrayit is supposed to be further along in the development of OvaDx. And I hope that they finish their clinical trials soon and submit the PMA. I have a lot more money invested in ARYC than in MBCI at this point. But to the best of my knowledge Arrayit has never made a public presentation of their preliminary results to a group of cancer specialists for peer review. And that is what Mabcure is doing this week at the annual meeting of the Society of Gynecological Oncologists (SGO).